NCT03419143View on ClinicalTrials.gov

Safety and Effectiveness of Abatacept in Psoriatic Arthritis Participants

CompletedOBSERVATIONAL
Enrollment

190

Participants

Timeline

Start Date

March 2, 2018

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
Psoriatic Arthritis (PsA)
Trial Locations (1)

90429

Local Institution - 0001, Nuremberg

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY